Novo Nordisk A/S (NYSE:NVO), from Healthcare sector has been on the upside of the performance spectrum.
Novo Nordisk A/S stated a price of 33.75 today, indicating a positive change of 1.11%.
Novo Nordisk A/S is operating with a market capitalization of 66011.96, with a return on assets (ROA) of 42.70% and an average volume of 3444.9.
At present the return on equity (ROE) stands at 91.10% and the debt to equity stands at 0.01.
(Good to know: Return on Equity [ROE] is the simple measurement of profitability that takes into account how many dollars of profit an organization makes with each dollar of shareholder’s equity.)
The 52-week high for Novo Nordisk A/S stands at -41.06% while the 52-week low stands at 9.26%.
The performance week for Novo Nordisk A/S is at -7.71% and the performance month is at -8.90%. The quarterly and half-yearly performance stats stands at -2.82% and -28.50% respectively.
The performance (Year to Date) is at -6.92%.
The simple 20 day moving average for Novo Nordisk A/S is -4.12% and the simple 200-day moving average is at -24.30%.
The volatility (week) for Novo Nordisk A/S is at 2.16% and the volatility (month) is at 1.49%
(Good to know: Volatility in finance basically means the degree of disparity of a trading price series over time as calculated by the standard deviation of returns.)
Novo Nordisk A/S’s short ratio is currently at 0.94 and the float short is at 0.27%.
Novo Nordisk A/S’s P/E ratio currently stands at 15.43, while the P/S ratio is at 4.08 and the potential growth rate of earnings per share this year is at 10.60%.